HROW Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Harrow Inc (HROW) is not a strong buy at the moment for a beginner investor with a long-term focus. While the company shows promising revenue growth and has positive analyst ratings, the recent price decline, lack of strong trading signals, and insider selling suggest caution. Holding the stock or waiting for a better entry point is recommended.
The technical indicators show mixed signals. The MACD is positive and expanding, indicating potential upward momentum, but the RSI is neutral at 46.306, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 34.835, with resistance at 36.256 and support at 33.414.
The company has announced a private offering of $50 million in senior unsecured notes to strengthen its capital structure and fund future growth. Revenue for Q4 2025 increased by 33.31% YoY, and gross margin improved slightly to 79.27%. Analysts maintain positive ratings with high price targets.
The stock has experienced a significant price decline (-2.67% in the regular market and -2.34% in pre-market). Insider selling by Opaleye Management Inc. of 198,572 shares for $7.8 million raises concerns. Net income and EPS have declined YoY, and there is no recent congress trading data to provide additional confidence.
In Q4 2025, Harrow's revenue increased by 33.31% YoY to $89.09 million, but net income dropped by -2.23% YoY to $6.63 million, and EPS fell by -5.26% YoY to 0.18. Gross margin improved slightly to 79.27%, indicating operational efficiency.
Analysts remain optimistic about Harrow, with recent price target adjustments reflecting a range of $60 to $91. Ladenburg, Cantor Fitzgerald, and Lake Street all lowered their targets but maintained Buy or Overweight ratings, while H.C. Wainwright slightly increased its target to $70.
